|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ENZO BIOCHEM INC, 10-Q, 2000-12-14 |
Next: POLYDEX PHARMACEUTICALS LTD/BAHAMAS, 10-Q, 2000-12-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUL-31-2001
<PERIOD-START> AUG-01-2000
<PERIOD-END> OCT-31-2000
<CASH> 53,536
<SECURITIES> 0
<RECEIVABLES> 53,583
<ALLOWANCES> (33,795)
<INVENTORY> 1,749
<CURRENT-ASSETS> 78,579
<PP&E> 8,072
<DEPRECIATION> (5,234)
<TOTAL-ASSETS> 93,639
<CURRENT-LIABILITIES> 2,916
<BONDS> 0
0
0
<COMMON> 256
<OTHER-SE> 97,770
<TOTAL-LIABILITY-AND-EQUITY> 93,639
<SALES> 13,859
<TOTAL-REVENUES> 13,859
<CGS> 3,918
<TOTAL-COSTS> 11,723
<OTHER-EXPENSES> 4,599
<LOSS-PROVISION> 3,206
<INTEREST-EXPENSE> (851)
<INCOME-PRETAX> 2,987
<INCOME-TAX> (1,314)
<INCOME-CONTINUING> 1,673
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,673
<EPS-BASIC> .07
<EPS-DILUTED> .06
</TABLE>
|
|